Akèy › Kansè pwostat › Illinois › Cicero
Etid klinik pou Kansè pwostat nan Cicero, IL
14 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Cicero (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Ap rekriteFaz 3
- Edward Hines Jr VA Hospital, Hines · 4 mi lwen
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Ap rekriteFaz 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi lwen
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
- Loyola University Medical Center, Maywood · 5 mi lwen
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Ap rekriteFaz 3
- Associated Urological Specialists - Chicago Ridge, Chicago Ridge · 10 mi lwen
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Ap rekriteFaz 3
- Research Site, Chicago Ridge · 10 mi lwen
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Ap rekriteFaz 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
- Elmhurst Memorial Hospital, Elmhurst · 10 mi lwen
- ak 1 plis
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Ap rekriteFaz 2
- Associated Urological Specialists, Chicago Ridge · 10 mi lwen
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Ap rekriteFaz 3
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi lwen
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Ap rekriteFaz 3
- Elmhurst Memorial Hospital, Elmhurst · 10 mi lwen
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Ap rekriteFaz 2/3
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi lwen
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
Ap rekriteFaz 2
- Northwestern University Oak Brook IL453, Oak Brook · 9 mi lwen
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
Ap rekriteFaz 2Volontè an sante akeyi
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi lwen
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Ap rekriteFaz 3
- Loyola University Medical Center, Maywood · 5 mi lwen
Etid Kansè pwostat nan lòt vil
- New York City, NY103 etid
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA59 etid
- St. Louis, MO46 etid
- Chicago, IL45 etid
- San Francisco, CA45 etid
- Philadelphia, PA44 etid
- Baltimore, MD43 etid
- Nashville, TN42 etid
- Seattle, WA42 etid
- Washington, DC38 etid
Lòt etid nan Cicero
- Kansè Poumon ki pa ti selil24 etid
- Kansè poumon17 etid
- Kansè (tout kalite)13 etid
- Leksemi mieloïd egi11 etid
- Kansè nan tete11 etid
- Kansè kolorektal10 etid
- Kansè vejik8 etid
- Kansè Metastatik7 etid
- Melanom7 etid
- Maladi kadyovaskilè7 etid
- Limfòm Burkitt6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.